Completed

Developing a New Therapy for GAD: Acceptance-Based CBT

What is being tested

Data Collection

Who is being recruted

Generalized Anxiety Disorder

+ Anxiety Disorders

+ Mental Disorders

Over 18 Years

+3 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 1

Interventional

Study Start: May 2002

See protocol details

Summary

Principal SponsorUniversity of Massachusetts, Boston

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2002

Actual date on which the first participant was enrolled.

Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Official TitleDeveloping a New Therapy for GAD: Acceptance-Based CBT

NCT00073632

Principal SponsorUniversity of Massachusetts, Boston

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Generalized Anxiety DisorderAnxiety DisordersMental Disorders

Criteria

2 inclusion criteria required to participate

Generalized Anxiety Disorder (GAD)

Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study

1 exclusion criteria prevent from participating

Bipolar disorder, psychotic disorder, or substance dependence

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Center for Anxiety and Related Disorders

Boston, United StatesOpen Center for Anxiety and Related Disorders in Google Maps

CompletedOne Study Center